NOVOZYMES: Partnering throughout the entire innovation journey
Discover how we helped Novozymes optimise their innovation processes from idea to concept to drive actionable business impact.
PÅ DANSK →
Novozymes OneHealth is the human health unit of one of the world’s leading biotech companies. They carry out research into solutions to help improve gut health for the 3 out of 5 people worldwide who struggle with regular digestive problems. And they are driven by a mission that solutions should not only provide relief to a specific problem but also be designed to meet the reality of consumers’ daily life and routines.
Ipsos has helped design and lead Novozymes OneHealth through an innovation journey.
The first phase uncovered the discomforts people experience and which solutions are more attractive, thus helping Novozymes to re-define the market and identify white spaces. The next phase focussed on the development of final concept and let its actual market potential unfold on selected main markets. When the final solution has been developed, the brand name, pricing, key messages etc. will be tested.
Discover how our innovation solutions can help you
The next great product innovations are always hidden in the detail. Ipsos helped us dig deeper beyond the frame, which has led to the innovation journey we have been on together. And their translation of the many insights into actionable recommendations helped us integrate consumer reality with our product development.
- Head of Digestive Health Venture at Novozymes
|
|
Be in the know!Sign up to Ipsos Insights to get a monthly email with invitations to events and webinars, case stories, POV’s, whitepapers and news. |
Follow us for many more insights:
 |
 |
 |
 |
![[WEBINAR 30/09] Fueling high pace decision-making through DIY research | Ipsos | Denmark](/sites/default/files/styles/related_more_insights/public/ct/event/2021-09/Carousel_DIY%20Webinar_1.jpg?itok=tIH26k8D)